Biosynex boosted by the very high demand for Covid-19 tests

(Boursier.com) – Biosynex still climbs 7.8% this Thursday to 26.16 euros, in a volume representing 2.3% of the round table. The title benefits from numerous articles evoking the high demand. Le Parisien indicates that the French leader in antigenic tests “is crumbling under orders from pharmacies”. He has hired 200 temporary workers and predicts that January will be his biggest month. Since the start of the fifth wave of Covid-19, the demand for self-tests from the group has indeed been racing. “From the beginning of December, we sold all our stocks in two weeks”, specifies even Oren Bitton, commercial director of the company, quoted by Le Parisien. The delivery time would have passed to a dozen days, and the group’s sales assistants would be drowning in calls from pharmacies for orders or reminders …